| Organism name | Strophanthus gratus | 
|---|---|
| Genus | Strophanthus | 
| Family | Apocynaceae | 
| Kingdom | Plantae | 
| Linked NCBI taxonomy name | Strophanthus gratus | 
|---|---|
| Linked NCBI taxonomy ID | 141614 | 
| Linked level | species | 
| Family in NCBI taxonomy | Apocynaceae | 
|---|---|
| ID | 4056 | 
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae | 
|---|---|
| ID | 33090 | 
| Plant class | asterids | 
|---|---|
| ID | 71274 | 
| Species | Activity | 
|---|---|
| Strophanthus gratus (Wall. & Hook.) Baill. | Anxiolytic | 
| Strophanthus gratus (Wall. & Hook.) Baill. | Cardiotonic | 
| Strophanthus gratus (Wall. & Hook.) Baill. | Curare | 
| Strophanthus gratus (Wall. & Hook.) Baill. | Digitalic | 
| Strophanthus gratus (Wall. & Hook.) Baill. | Diuretic | 
| Strophanthus gratus (Wall. & Hook.) Baill. | Negative Chronotropic | 
| Strophanthus gratus (Wall. & Hook.) Baill. | Negative Dromotropic | 
| Strophanthus gratus (Wall. & Hook.) Baill. | Pediculicide | 
| Strophanthus gratus (Wall. & Hook.) Baill. | Positive Bathmotropic | 
| Strophanthus gratus (Wall. & Hook.) Baill. | Positive Inotropic | 
| KNApSAcK ID | name | ChEMBL link | CTD link | # of proteins in ChEMBL interaction / related OMIM / related KEGG DISEASE | # of genes in CTD interaction / related diseases | KCF-S cluster | phytochemical cluster | figure | 
|---|---|---|---|---|---|---|---|---|
| C00007190   | (+)-Pinoresinol | CHEMBL267963 CHEMBL487611 CHEMBL460862 | C103298 | 7 / 5 / 6 | No. 38 | No. 21 |   | |
| C00003633   | Ouabain | CHEMBL222863 CHEMBL1320401 CHEMBL1493751 CHEMBL1512393 CHEMBL1524156 CHEMBL1591556 CHEMBL1617838 CHEMBL1720907 CHEMBL2069120 | D010042 | 120 / 82 / 78 | 83 / 33 | No. 109 | No. 56 |   | 
| C00000682   | (-)-Olivil / Vladinol C | CHEMBL517144 | 1 / 1 / 1 | No. 700 | No. 21 |   | ||
| C00007191   | (+)-8(1)-Hydroxypinoresinol | CHEMBL471274 | No. 700 | No. 21 |   | 
| accession | description | class description | KNApSAcK metabolite in interactions | # of diseases (OMIM / KEGG) | 
|---|---|---|---|---|
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00003633 C00007190 | 0 / 3 | 
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00003633 C00007190 | 0 / 0 | 
| P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00003633 | 0 / 0 | 
| Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | Electrochemical transporter | C00003633 | 1 / 0 | 
| O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | C00003633 | 0 / 0 | 
| Q99700 | Ataxin-2 | Unclassified protein | C00003633 | 1 / 1 | 
| P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00007190 | 0 / 0 | 
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00003633 | 0 / 0 | 
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00003633 | 1 / 0 | 
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00003633 | 2 / 2 | 
| P08246 | Neutrophil elastase | S1A | C00003633 | 2 / 1 | 
| P33765 | Adenosine receptor A3 | Adenosine receptor | C00003633 | 0 / 0 | 
| Q16539 | Mitogen-activated protein kinase 14 | p38 | C00003633 | 0 / 0 | 
| P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00003633 | 0 / 0 | 
| P29466 | Caspase-1 | C14 | C00003633 | 0 / 0 | 
| P17252 | Protein kinase C alpha type | Alpha | C00003633 | 0 / 0 | 
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00003633 | 0 / 0 | 
| Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00007190 | 0 / 0 | 
| P14780 | Matrix metalloproteinase-9 | M10A | C00003633 | 2 / 2 | 
| P02545 | Prelamin-A/C | Unclassified protein | C00003633 | 11 / 10 | 
| A2TJX0 | Krueppel-like factor 5 | Unclassified protein | C00003633 | 0 / 0 | 
| P16473 | Thyrotropin receptor | Glycohormone receptor | C00003633 | 3 / 2 | 
| P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00000682 | 1 / 1 | 
| P00918 | Carbonic anhydrase 2 | Lyase | C00003633 | 1 / 2 | 
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00003633 | 0 / 1 | 
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00003633 | 1 / 1 | 
| P25021 | Histamine H2 receptor | Histamine receptor | C00003633 | 0 / 0 | 
| P35367 | Histamine H1 receptor | Histamine receptor | C00003633 | 0 / 0 | 
| Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00003633 | 1 / 0 | 
| P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00003633 | 0 / 0 | 
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00003633 | 0 / 0 | 
| P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00003633 | 0 / 0 | 
| P02768 | Serum albumin | Secreted protein | C00003633 | 0 / 0 | 
| P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00003633 | 0 / 0 | 
| P06241 | Tyrosine-protein kinase Fyn | Src | C00003633 | 0 / 0 | 
| Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00003633 | 0 / 0 | 
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00003633 | 0 / 1 | 
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00003633 | 1 / 8 | 
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00003633 | 2 / 0 | 
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00003633 | 0 / 0 | 
| P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00003633 | 0 / 0 | 
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00003633 | 0 / 0 | 
| Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00003633 | 0 / 0 | 
| P29274 | Adenosine receptor A2a | Adenosine receptor | C00003633 | 0 / 0 | 
| P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00003633 | 0 / 0 | 
| P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00003633 | 1 / 1 | 
| P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00003633 | 0 / 0 | 
| P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00003633 | 1 / 0 | 
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00003633 | 0 / 0 | 
| Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00003633 | 0 / 0 | 
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00003633 | 0 / 0 | 
| P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00003633 | 2 / 0 | 
| O75496 | Geminin | Unclassified protein | C00003633 | 0 / 0 | 
| P51151 | Ras-related protein Rab-9A | Unclassified protein | C00003633 | 0 / 0 | 
| Q8TCC7 | Solute carrier family 22 member 8 | Antiporter | C00003633 | 0 / 0 | 
| P46721 | Solute carrier organic anion transporter family member 1A2 | Unclassified protein | C00003633 | 0 / 0 | 
| P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00003633 | 0 / 0 | 
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00003633 | 0 / 0 | 
| P21917 | D(4) dopamine receptor | Dopamine receptor | C00003633 | 0 / 0 | 
| P30988 | Calcitonin receptor | Calcitonin receptor | C00003633 | 0 / 0 | 
| P35462 | D(3) dopamine receptor | Dopamine receptor | C00003633 | 1 / 0 | 
| P41143 | Delta-type opioid receptor | Opioid receptor | C00003633 | 0 / 0 | 
| Q92731 | Estrogen receptor beta | NR3A2 | C00003633 | 0 / 1 | 
| Q16637 | Survival motor neuron protein | Unclassified protein | C00003633 | 4 / 1 | 
| P25101 | Endothelin-1 receptor | Endothelin receptor | C00003633 | 0 / 0 | 
| P30411 | B2 bradykinin receptor | Bradykinin receptor | C00003633 | 0 / 0 | 
| P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00003633 | 1 / 0 | 
| P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00003633 | 0 / 0 | 
| P08311 | Cathepsin G | S1A | C00003633 | 0 / 0 | 
| Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00003633 | 1 / 0 | 
| P40763 | Signal transducer and activator of transcription 3 | Transcription Factor | C00003633 | 1 / 2 | 
| P03956 | Interstitial collagenase | M10A | C00003633 | 0 / 1 | 
| P54707 | Potassium-transporting ATPase alpha chain 2 | Potassium-transporting P-type ATPase alpha subunit | C00003633 | 0 / 0 | 
| P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00003633 | 0 / 0 | 
| P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00003633 | 7 / 3 | 
| Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | Electrochemical transporter | C00003633 | 1 / 0 | 
| P04150 | Glucocorticoid receptor | NR3C1 | C00003633 | 0 / 1 | 
| P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00003633 | 2 / 0 | 
| P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00003633 | 0 / 0 | 
| P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00003633 | 0 / 0 | 
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00003633 | 2 / 0 | 
| P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00007190 | 5 / 3 | 
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00003633 | 5 / 9 | 
| P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00003633 | 1 / 0 | 
| P21452 | Substance-K receptor | Neurokinin receptor | C00003633 | 0 / 0 | 
| P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00003633 | 0 / 0 | 
| P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00003633 | 3 / 0 | 
| P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00003633 | 0 / 0 | 
| P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00003633 | 1 / 0 | 
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00003633 | 0 / 0 | 
| P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00003633 | 2 / 1 | 
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00003633 | 0 / 0 | 
| O15118 | Niemann-Pick C1 protein | Unclassified protein | C00003633 | 1 / 1 | 
| Q01453 | Peripheral myelin protein 22 | Unclassified protein | C00003633 | 5 / 2 | 
| P04637 | Cellular tumor antigen p53 | Transcription Factor | C00003633 | 7 / 37 | 
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00003633 | 0 / 0 | 
| P03372 | Estrogen receptor | NR3A1 | C00003633 | 1 / 1 | 
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00003633 | 1 / 0 | 
| P22303 | Acetylcholinesterase | Hydrolase | C00003633 | 1 / 0 | 
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00003633 | 0 / 0 | 
| P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00003633 | 0 / 0 | 
| P35372 | Mu-type opioid receptor | Opioid receptor | C00003633 | 0 / 0 | 
| P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00003633 | 0 / 0 | 
| P25103 | Substance-P receptor | Neurokinin receptor | C00003633 | 0 / 0 | 
| P25105 | Platelet-activating factor receptor | PAF receptor | C00003633 | 0 / 0 | 
| P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00003633 | 0 / 0 | 
| P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00003633 | 0 / 0 | 
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00003633 | 1 / 1 | 
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00003633 | 0 / 1 | 
| P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00003633 | 0 / 0 | 
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00003633 | 0 / 0 | 
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00003633 | 1 / 1 | 
| P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00003633 | 0 / 0 | 
| P30542 | Adenosine receptor A1 | Adenosine receptor | C00003633 | 0 / 0 | 
| Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00007190 | 0 / 0 | 
| P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00003633 | 0 / 0 | 
| P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00003633 | 1 / 1 | 
| P06239 | Tyrosine-protein kinase Lck | Src | C00003633 | 0 / 1 | 
| P31939 | Bifunctional purine biosynthesis protein PURH | Enzyme | C00003633 | 1 / 1 | 
| P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00003633 | 0 / 0 | 
| P42224 | Signal transducer and activator of transcription 1-alpha/beta | Unclassified protein | C00003633 | 3 / 3 | 
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00003633 | 0 / 0 | 
| O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00003633 | 1 / 0 | 
| Q6ZQN7 | Solute carrier organic anion transporter family member 4C1 | Unclassified protein | C00003633 | 0 / 0 | 
| Q9NYB5 | Solute carrier organic anion transporter family member 1C1 | Unclassified protein | C00003633 | 0 / 0 | 
| Q9H0H5 | Rac GTPase-activating protein 1 | Unclassified protein | C00007190 | 0 / 0 | 
| gene | gene name | gene description | KNApSAcK metabolite in interactions | 
|---|---|---|---|
| 2 | A2M, A2MD, CPAMD5, FWP007, S863-7 | alpha-2-macroglobulin | C00003633 | 
| 5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | C00003633 | 
| 10449 | ACAA2, DSAEC | acetyl-CoA acyltransferase 2 (EC:2.3.1.16) | C00003633 | 
| 59 | ACTA2, AAT6, ACTSA, MYMY5 | actin, alpha 2, smooth muscle, aorta | C00003633 | 
| 126 | ADH1C, ADH3 | alcohol dehydrogenase 1C (class I), gamma polypeptide (EC:1.1.1.1) | C00003633 | 
| 301 | ANXA1, ANX1, LPC1 | annexin A1 | C00003633 | 
| 302 | ANXA2, ANX2, ANX2L4, CAL1H, LIP2, LPC2, LPC2D, P36, PAP-IV | annexin A2 | C00003633 | 
| 369 | ARAF, A-RAF, ARAF1, PKS2, RAFA1 | v-raf murine sarcoma 3611 viral oncogene homolog (EC:2.7.11.1) | C00003633 | 
| 25820 | ARIH1, ARI, HARI, HHARI, UBCH7BP | ariadne RBR E3 ubiquitin protein ligase 1 | C00003633 | 
| 10092 | ARPC5, ARC16, dJ127C7.3, p16-Arc | actin related protein 2/3 complex, subunit 5, 16kDa | C00003633 | 
| 408 | ARRB1, ARB1, ARR1 | arrestin, beta 1 | C00003633 | 
| 427 | ASAH1, AC, ACDase, ASAH, PHP, PHP32, SMAPME | N-acylsphingosine amidohydrolase (acid ceramidase) 1 (EC:3.5.1.23) | C00003633 | 
| 479 | ATP12A, ATP1AL1 | ATPase, H+/K+ transporting, nongastric, alpha polypeptide (EC:3.6.3.10) | C00003633 | 
| 476 | ATP1A1 | ATPase, Na+/K+ transporting, alpha 1 polypeptide (EC:3.6.3.9) | C00003633 | 
| 477 | ATP1A2, FHM2, MHP2 | ATPase, Na+/K+ transporting, alpha 2 polypeptide (EC:3.6.3.9) | C00003633 | 
| 478 | ATP1A3, AHC2, DYT12, RDP | ATPase, Na+/K+ transporting, alpha 3 polypeptide (EC:3.6.3.9) | C00003633 | 
| 496 | ATP4B, ATP6B | ATPase, H+/K+ exchanging, beta polypeptide | C00003633 | 
| 498 | ATP5A1, ATP5A, ATP5AL2, ATPM, MC5DN4, MOM2, OMR, ORM, hATP1 | ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle | C00003633 | 
| 22893 | BAHD1 | bromo adjacent homology domain containing 1 | C00003633 | 
| 581 | BAX, BCL2L4 | BCL2-associated X protein | C00003633 | 
| 51806 | CALML5, CLSP | calmodulin-like 5 | C00003633 | 
| 821 | CANX, CNX, IP90, P90 | calnexin | C00003633 | 
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | C00003633 | 
| 64770 | CCDC14 | coiled-coil domain containing 14 | C00003633 | 
| 8900 | CCNA1 | cyclin A1 | C00003633 | 
| 890 | CCNA2, CCN1, CCNA | cyclin A2 | C00003633 | 
| 1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) | C00003633 | 
| 1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | C00003633 | 
| 9076 | CLDN1, CLD1, ILVASC, SEMP1 | claudin 1 | C00003633 | 
| 10330 | CNPY2, HP10390, MSAP, TMEM4, ZSIG9 | canopy FGF signaling regulator 2 | C00003633 | 
| 1537 | CYC1, MC3DN6, UQCR4 | cytochrome c-1 | C00003633 | 
| 1650 | DDOST, AGER1, CDG1R, OKSWcl45, OST, OST48, WBP1 | dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit (non-catalytic) (EC:2.4.99.18) | C00003633 | 
| 1812 | DRD1, DADR, DRD1A | dopamine receptor D1 | C00003633 | 
| 1828 | DSG1, CDHF4, DG1, DSG, EPKHIA, PPKS1, SPPK1 | desmoglein 1 | C00003633 | 
| 1854 | DUT, dUTPase | deoxyuridine triphosphatase (EC:3.6.1.23) | C00003633 | 
| 1889 | ECE1, ECE | endothelin converting enzyme 1 (EC:3.4.24.71) | C00003633 | 
| 1892 | ECHS1, SCEH | enoyl CoA hydratase, short chain, 1, mitochondrial (EC:4.2.1.17) | C00003633 | 
| 27335 | EIF3K, EIF3-p28, EIF3S12, HSPC029, M9, MSTP001, PLAC-24, PLAC24, PRO1474, PTD001 | eukaryotic translation initiation factor 3, subunit K | C00003633 | 
| 10667 | FARS2, COXPD14, FARS1, HSPC320, PheRS, dJ520B18.2 | phenylalanyl-tRNA synthetase 2, mitochondrial (EC:6.1.1.20) | C00003633 | 
| 2271 | FH, HLRCC, LRCC, MCL, MCUL1 | fumarate hydratase (EC:4.2.1.2) | C00003633 | 
| 51661 | FKBP7, FKBP23, PPIase | FK506 binding protein 7 (EC:5.2.1.8) | C00003633 | 
| 2638 | GC, DBP, DBP/GC, GRD3, VDBG, VDBP | group-specific component (vitamin D binding protein) (EC:6.4.-.-) | C00003633 | 
| 2743 | GLRB, HKPX2 | glycine receptor, beta | C00003633 | 
| 8225 | GTPBP6, PGPL | GTP binding protein 6 (putative) | C00003633 | 
| 3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | C00003633 | 
| 3181 | HNRNPA2B1, HNRNPA2, HNRNPB1, HNRPA2, HNRPA2B1, HNRPB1, IBMPFD2, RNPA2, SNRPB1 | heterogeneous nuclear ribonucleoprotein A2/B1 | C00003633 | 
| 9987 | HNRNPDL, HNRNP, HNRPDL, JKTBP, JKTBP2, laAUF1 | heterogeneous nuclear ribonucleoprotein D-like | C00003633 | 
| 3241 | HPCAL1, BDR1, HLP2, VILIP-3 | hippocalcin-like 1 | C00003633 | 
| 3273 | HRG, HPRG, HRGP, THPH11 | histidine-rich glycoprotein | C00003633 | 
| 3329 | HSPD1, CPN60, GROEL, HLD4, HSP-60, HSP60, HSP65, HuCHA60, SPG13 | heat shock 60kDa protein 1 (chaperonin) | C00003633 | 
| 3559 | IL2RA, CD25, IDDM10, IL2R, TCGFR | interleukin 2 receptor, alpha | C00003633 | 
| 3560 | IL2RB, CD122, IL15RB, P70-75 | interleukin 2 receptor, beta | C00003633 | 
| 3751 | KCND2, KV4.2, RK5 | potassium voltage-gated channel, Shal-related subfamily, member 2 | C00003633 | 
| 3757 | KCNH2, ERG1, HERG, HERG1, Kv11.1, LQT2, SQT1 | potassium voltage-gated channel, subfamily H (eag-related), member 2 | C00003633 | 
| 3956 | LGALS1, GAL1, GBP | lectin, galactoside-binding, soluble, 1 | C00003633 | 
| 4047 | LSS, OSC | lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) (EC:5.4.99.7) | C00003633 | 
| 5598 | MAPK7, BMK1, ERK4, ERK5, PRKM7 | mitogen-activated protein kinase 7 (EC:2.7.11.24) | C00003633 | 
| 4191 | MDH2, M-MDH, MDH, MGC:3559, MOR1 | malate dehydrogenase 2, NAD (mitochondrial) (EC:1.1.1.37) | C00003633 | 
| 4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog | C00003633 | 
| 10627 | MYL12A, MLCB, MRCL3, MRLC3, MYL2B | myosin, light chain 12A, regulatory, non-sarcomeric | C00003633 | 
| 10577 | NPC2, EDDM1, HE1 | Niemann-Pick disease, type C2 | C00003633 | 
| 5111 | PCNA | proliferating cell nuclear antigen | C00003633 | 
| 10016 | PDCD6, ALG-2, PEF1B | programmed cell death 6 | C00003633 | 
| 5204 | PFDN5, MM-1, MM1, PFD5 | prefoldin subunit 5 | C00003633 | 
| 5216 | PFN1, ALS18 | profilin 1 | C00003633 | 
| 9374 | PPT2, C6orf8, G14, PPT-2 | palmitoyl-protein thioesterase 2 (EC:3.1.2.22) | C00003633 | 
| 5694 | PSMB6, DELTA, LMPY, Y | proteasome (prosome, macropain) subunit, beta type, 6 (EC:3.4.25.1) | C00003633 | 
| 5771 | PTPN2, PTN2, PTPT, TC-PTP, TCELLPTP, TCPTP | protein tyrosine phosphatase, non-receptor type 2 (EC:3.1.3.48) | C00003633 | 
| 9230 | RAB11B, H-YPT3 | RAB11B, member RAS oncogene family | C00003633 | 
| 6093 | ROCK1, P160ROCK, ROCK-I | Rho-associated, coiled-coil containing protein kinase 1 (EC:2.7.11.1) | C00003633 | 
| 9475 | ROCK2, ROCK-II | Rho-associated, coiled-coil containing protein kinase 2 (EC:2.7.11.1) | C00003633 | 
| 6119 | RPA3, REPA3 | replication protein A3, 14kDa | C00003633 | 
| 23322 | RPGRIP1L, CORS3, FTM, JBTS7, MKS5, NPHP8 | RPGRIP1-like | C00003633 | 
| 6284 | S100A13 | S100 calcium binding protein A13 | C00003633 | 
| 6446 | SGK1, SGK | serum/glucocorticoid regulated kinase 1 (EC:2.7.11.1) | C00003633 | 
| 10110 | SGK2, H-SGK2, dJ138B7.2 | serum/glucocorticoid regulated kinase 2 (EC:2.7.11.1) | C00003633 | 
| 23678 | SGK3, CISK, SGK2, SGKL | serum/glucocorticoid regulated kinase family, member 3 (EC:2.7.11.1) | C00003633 | 
| 6528 | SLC5A5, NIS, TDH1 | solute carrier family 5 (sodium/iodide cotransporter), member 5 | C00003633 | 
| 8884 | SLC5A6, SMVT | solute carrier family 5 (sodium/multivitamin and iodide cotransporter), member 6 | C00003633 | 
| 7167 | TPI1, TIM, TPI, TPID | triosephosphate isomerase 1 (EC:5.3.1.1) | C00003633 | 
| 7178 | TPT1, HRF, TCTP, p02, p23 | tumor protein, translationally-controlled 1 | C00003633 | 
| 7295 | TXN, TRDX, TRX, TRX1 | thioredoxin | C00003633 | 
| 463 | ZFHX3, ATBF1, ATBT, ZNF927 | zinc finger homeobox 3 | C00003633 | 
| OMIM | preferred title | UniProt | 
|---|---|---|
| #100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism | P20309 | 
| #219080 | Acth-independent macronodular adrenal hyperplasia; aimah | P63092 | 
| #202300 | Adrenocortical carcinoma, hereditary; adcc | P04637 | 
| #608688 | Aicar transformylase/imp cyclohydrolase deficiency | P31939 | 
| #103780 | Alcohol dependence | P08172 P14416 P31645 | 
| #614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 | Q99720 | 
| #209950 | Atypical mycobacteriosis, familial | P42224 | 
| #614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 | P04637 | 
| #602025 | Body mass index quantitative trait locus 9; bmiq9 | P41968 | 
| %606641 | Body mass index; bmi | P37231 | 
| #300615 | Brunner syndrome | P21397 | 
| #614162 | Candidiasis, familial, 7; candf7 | P42224 | 
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a | P02545 | 
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism | P02545 | 
| #609338 | Carotid intimal medial thickness 1 | P37231 | 
| #118300 | Charcot-marie-tooth disease and deafness | Q01453 | 
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 | P02545 | 
| #118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a | Q01453 | 
| #114500 | Colorectal cancer; crc | P84022 | 
| #162800 | Cyclic neutropenia | P08246 | 
| #612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 | P51681 | 
| #609535 | Drug metabolism, poor, cyp2c19-related | P33261 | 
| #608902 | Drug metabolism, poor, cyp2d6-related | P10635 | 
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 | P02545 | 
| #133239 | Esophageal cancer | P04637 | 
| #615363 | Estrogen resistance; estrr | P03372 | 
| #613659 | Gastric cancer | P04626 | 
| #137215 | Gastric cancer, hereditary diffuse; hdgc | P04626 | 
| #231095 | Ghosal hematodiaphyseal dysplasia; ghdd | P24557 | 
| #137800 | Glioma susceptibility 1; glm1 | O75874 P04626 P37231 | 
| #139393 | Guillain-barre syndrome, familial; gbs | Q01453 | 
| #610140 | Heart-hand syndrome, slovenian type | P02545 | 
| #609423 | Human immunodeficiency virus type 1, susceptibility to | P41597 P51681 | 
| #176670 | Hutchinson-gilford progeria syndrome; hgps | P02545 | 
| #147060 | Hyper-ige recurrent infection syndrome, autosomal dominant | P40763 | 
| #237450 | Hyperbilirubinemia, rotor type; hblrr | Q9NPD5 Q9Y6L6 | 
| #603373 | Hyperthyroidism, familial gestational | P16473 | 
| #609152 | Hyperthyroidism, nonautoimmune | P16473 | 
| #145900 | Hypertrophic neuropathy of dejerine-sottas | Q01453 | 
| #275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 | P16473 | 
| #603932 | Intervertebral disc disease; idd | P14780 | 
| #151623 | Li-fraumeni syndrome 1; lfs1 | P04637 | 
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 | P02545 | 
| #604367 | Lipodystrophy, familial partial, type 3; fpld3 | P37231 | 
| #613795 | Loeys-dietz syndrome, type 3; lds3 | P84022 | 
| #613688 | Long qt syndrome 2; lqt2 | Q12809 | 
| #211980 | Lung cancer | P00533 P04626 P04637 | 
| #608516 | Major depressive disorder; mdd | P08172 | 
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada | P02545 | 
| #174800 | Mccune-albright syndrome; mas | P63092 | 
| %300852 | Mental retardation, x-linked 88; mrx88 | P50052 | 
| #613073 | Metaphyseal anadysplasia 2; mandp2 | P14780 | 
| #126200 | Multiple sclerosis, susceptibility to; ms | P08575 | 
| #613205 | Muscular dystrophy, congenital, lmna-related | P02545 | 
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b | P02545 | 
| #613796 | Mycobacterial and viral infections, susceptibility to, autosomal recessive | P42224 | 
| #159900 | Myoclonic dystonia | P14416 | 
| #162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp | Q01453 | 
| #202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 | P08246 | 
| #257220 | Niemann-pick disease, type c1; npc1 | O15118 | 
| #601665 | Obesity | P32245 P37231 | 
| #164230 | Obsessive-compulsive disorder; ocd | P31645 | 
| #604715 | Orthostatic intolerance | P23975 | 
| #166350 | Osseous heteroplasia, progressive; poh | P63092 | 
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 | P00918 | 
| #167000 | Ovarian cancer | P04626 | 
| #260500 | Papilloma of choroid plexus; cpp | P04637 | 
| #613135 | Parkinsonism-dystonia, infantile; pkdys | Q01959 | 
| #102200 | Pituitary adenoma, growth hormone-secreting | P63092 | 
| #103580 | Pseudohypoparathyroidism, type ia; php1a | P63092 | 
| #603233 | Pseudohypoparathyroidism, type ib; php1b | P63092 | 
| #612462 | Pseudohypoparathyroidism, type ic; php1c | P63092 | 
| #607276 | Resting heart rate, variation in | P08588 | 
| #275210 | Restrictive dermopathy, lethal | P02545 | 
| #608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive | P08575 | 
| #609620 | Short qt syndrome 1; sqt1 | Q12809 | 
| #253300 | Spinal muscular atrophy, type i; sma1 | Q16637 | 
| #253550 | Spinal muscular atrophy, type ii; sma2 | Q16637 | 
| #253400 | Spinal muscular atrophy, type iii; sma3 | Q16637 | 
| #271150 | Spinal muscular atrophy, type iv; sma4 | Q16637 | 
| #183090 | Spinocerebellar ataxia 2; sca2 | Q99700 | 
| #275355 | Squamous cell carcinoma, head and neck; hnscc | P04637 | 
| #190300 | Tremor, hereditary essential, 1; etm1 | P35462 | 
| #610379 | West nile virus, susceptibility to | P51681 | 
| #278300 | Xanthinuria, type i | P47989 | 
| #112100 | Yt blood group antigen | P22303 | 
| KEGG | name | UniProt | 
|---|---|---|
| H00136 | Niemann-Pick disease type C (NPC) | O15118
                            (related) | 
| H00016 | Oral cancer | P00533
                            (related) P00533 (marker) P04637 (related) P04637 (marker) P40763 (related) | 
| H00017 | Esophageal cancer | P00533
                            (related) P04637 (related) P04637 (marker) P35354 (related) | 
| H00018 | Gastric cancer | P00533
                            (related) P04626 (related) P04637 (related) | 
| H00022 | Bladder cancer | P00533
                            (related) P04626 (related) P04637 (related) | 
| H00028 | Choriocarcinoma | P00533
                            (related) P03956 (related) P04626 (related) P04637 (related) | 
| H00030 | Cervical cancer | P00533
                            (related) P04626 (related) | 
| H00042 | Glioma | P00533
                            (related) P00533 (marker) P04637 (related) P04637 (marker) | 
| H00055 | Laryngeal cancer | P00533
                            (related) P00533 (marker) P04637 (related) P04637 (marker) | 
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) | P00918
                            (related) | 
| H00436 | Osteopetrosis | P00918
                            (related) | 
| H00264 | Charcot-Marie-Tooth disease (CMT) | P02545
                            (related) Q01453 (related) | 
| H00294 | Dilated cardiomyopathy (DCM) | P02545
                            (related) | 
| H00420 | Familial partial lipodystrophy (FPL) | P02545
                            (related) P37231 (related) | 
| H00563 | Emery-Dreifuss muscular dystrophy | P02545
                            (related) | 
| H00590 | Congenital muscular dystrophies (CMD/MDC) | P02545
                            (related) | 
| H00593 | Limb-girdle muscular dystrophy (LGMD) | P02545
                            (related) | 
| H00601 | Hutchinson-Gilford progeria syndrome | P02545
                            (related) | 
| H00663 | Restrictive dermopathy | P02545
                            (related) | 
| H00665 | Mandibuloacral dysplasia | P02545
                            (related) | 
| H01216 | Left ventricular noncompaction (LVNC) | P02545
                            (related) | 
| H00026 | Endometrial Cancer | P03372
                            (marker) P04626 (related) P04637 (related) Q92731 (marker) | 
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) | P04150
                            (related) | 
| H00019 | Pancreatic cancer | P04626
                            (related) P04637 (related) P04637 (marker) | 
| H00027 | Ovarian cancer | P04626
                            (related) P04637 (related) | 
| H00031 | Breast cancer | P04626
                            (related) P04626 (marker) P04637 (related) | 
| H00046 | Cholangiocarcinoma | P04626
                            (related) P04637 (related) P35354 (related) | 
| H00004 | Chronic myeloid leukemia (CML) | P04637
                            (related) | 
| H00005 | Chronic lymphocytic leukemia (CLL) | P04637
                            (related) | 
| H00006 | Hairy-cell leukemia | P04637
                            (related) | 
| H00008 | Burkitt lymphoma | P04637
                            (related) | 
| H00009 | Adult T-cell leukemia | P04637
                            (related) | 
| H00010 | Multiple myeloma | P04637
                            (related) | 
| H00013 | Small cell lung cancer | P04637
                            (related) | 
| H00014 | Non-small cell lung cancer | P04637
                            (related) | 
| H00015 | Malignant pleural mesothelioma | P04637
                            (related) | 
| H00020 | Colorectal cancer | P04637
                            (related) P04637 (marker) | 
| H00025 | Penile cancer | P04637
                            (related) P04637 (marker) P14780 (related) P35354 (related) | 
| H00029 | Vulvar cancer | P04637
                            (related) | 
| H00032 | Thyroid cancer | P04637
                            (related) P37231 (related) | 
| H00033 | Adrenal carcinoma | P04637
                            (related) | 
| H00036 | Osteosarcoma | P04637
                            (related) P08684 (marker) | 
| H00038 | Malignant melanoma | P04637
                            (related) | 
| H00039 | Basal cell carcinoma | P04637
                            (related) | 
| H00040 | Squamous cell carcinoma | P04637
                            (related) | 
| H00041 | Kaposi's sarcoma | P04637
                            (related) | 
| H00044 | Cancer of the anal canal | P04637
                            (related) | 
| H00047 | Gallbladder cancer | P04637
                            (related) | 
| H00048 | Hepatocellular carcinoma | P04637
                            (related) | 
| H00881 | Li-Fraumeni syndrome | P04637
                            (related) | 
| H01007 | Choroid plexus papilloma | P04637
                            (related) | 
| H00021 | Renal cell carcinoma | P04637
                            (marker) | 
| H00093 | Combined immunodeficiencies (CIDs) | P06239
                            (related) | 
| H00079 | Asthma | P07550
                            (related) | 
| H00100 | Neutropenic disorders | P08246
                            (related) | 
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs) | P08575
                            (related) | 
| H01205 | Coumarin resistance | P11712
                            (related) | 
| H00479 | Metaphyseal dysplasias | P14780
                            (related) | 
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) | P16473
                            (related) | 
| H01269 | Congenital hyperthyroidism | P16473
                            (related) | 
| H00548 | Brunner syndrome | P21397
                            (related) | 
| H01031 | Orthostatic intolerance (OI) | P23975
                            (related) | 
| H00490 | Diaphyseal dysplasia with anemia (Ghosal) | P24557
                            (related) | 
| H00966 | AICA-ribosiduria | P31939
                            (related) | 
| H01171 | Poor drug metabolism (PM) | P33261
                            (related) | 
| H00409 | Type II diabetes mellitus | P37231
                            (related) | 
| H00107 | Other well-defined immunodeficiency syndromes | P40763
                            (related) | 
| H00089 | IFN-gamma/IL-12 axis | P42224
                            (related) | 
| H00363 | Candidiasis | P42224
                            (related) | 
| H01109 | Chronic mucocutaneous candidiasis (CMC) | P42224
                            (related) | 
| H00192 | Xanthinuria | P47989
                            (related) | 
| H00480 | Non-syndromic X-linked mental retardation | P50052
                            (related) | 
| H00244 | Pseudohypoparathyroidism | P63092
                            (related) | 
| H00441 | Progressive osseous heteroplasia (POH) | P63092
                            (related) | 
| H00501 | Fibrous dysplasia, polyostotic | P63092
                            (related) | 
| H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) | Q01453
                            (related) | 
| H00720 | Long QT syndrome | Q12809
                            (related) | 
| H00725 | Short QT syndrome | Q12809
                            (related) | 
| H00455 | Spinal muscular atrophy (SMA) | Q16637
                            (related) | 
| H00063 | Spinocerebellar ataxia (SCA) | Q99700
                            (related) | 
| MESH or OMIM | name | KNApSAcK metabolite | 
|---|---|---|
| D000014 | Abnormalities, Drug-Induced | C00003633 | 
| D000647 | Amnesia | C00003633 | 
| D001145 | Arrhythmias, Cardiac | C00003633 | 
| D001281 | Atrial Fibrillation | C00003633 | 
| D001714 | Bipolar Disorder | C00003633 | 
| D001919 | Bradycardia | C00003633 | 
| D001927 | Brain Diseases | C00003633 | 
| D001929 | Brain Edema | C00003633 | 
| D020520 | Brain Infarction | C00003633 | 
| D001930 | Brain Injuries | C00003633 | 
| D002303 | Cardiac Output, Low | C00003633 | 
| D006332 | Cardiomegaly | C00003633 | 
| D003251 | Constriction, Pathologic | C00003633 | 
| D064420 | Drug-Related Side Effects and Adverse Reactions | C00003633 | 
| D006323 | Heart Arrest | C00003633 | 
| D006327 | Heart Block | C00003633 | 
| D006331 | Heart Diseases | C00003633 | 
| D006948 | Hyperkinesis | C00003633 | 
| D006973 | Hypertension | C00003633 | 
| D020925 | Hypoxia-Ischemia, Brain | C00003633 | 
| D009336 | Necrosis | C00003633 | 
| D009410 | Nerve Degeneration | C00003633 | 
| D010243 | Paralysis | C00003633 | 
| D012164 | Retinal Diseases | C00003633 | 
| D012640 | Seizures | C00003633 | 
| D020182 | Sleep Apnea, Central | C00003633 | 
| D013610 | Tachycardia | C00003633 | 
| D013616 | Tachycardia, Sinus | C00003633 | 
| D017180 | Tachycardia, Ventricular | C00003633 | 
| D014570 | Urologic Diseases | C00003633 | 
| D014693 | Ventricular Fibrillation | C00003633 | 
| D018879 | Ventricular Premature Complexes | C00003633 | 
| D015837 | Vestibular Diseases | C00003633 |